Literature DB >> 6688205

An evaluation of plasma exchange for Graves' ophthalmopathy.

W Kelly, D Longson, D Smithard, R Fawcitt, R Wensley, J Noble, J Keeley.   

Abstract

Eighteen patients with ocular manifestations of Graves' disease were treated by plasma exchange. Detailed clinical, ophthalmological and orthoptic assessments were made including computerized axial tomography and A + B scan ultrasound of the orbits. Seventeen different ocular parameters were separately rated for each patient. The changes recorded were small, statistically insignificant, and no patient was cured of ocular disease. There were no significant correlations between the ocular changes recorded and age, sex, duration of ophthalmic symptoms, the presence of thyroid antibodies, the number of exchanges, or the concurrent administration of azathioprine.

Entities:  

Mesh:

Year:  1983        PMID: 6688205     DOI: 10.1111/j.1365-2265.1983.tb02878.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  10 in total

1.  Emergency laparotomy in uncontrolled thyrotoxic patient with preoperative fulminant hepatic failure.

Authors:  S Kiyama; T Yoshikawa; H Ozawa; H Koh; H Maki; K Tsuzaki; K Fukushima
Journal:  J Anesth       Date:  1993-01       Impact factor: 2.078

Review 2.  Immunosuppressant therapy of thyroid eye disease.

Authors:  G Kahaly; J Beyer
Journal:  Klin Wochenschr       Date:  1988-11-01

3.  The pathogenesis and treatment of Graves' ophthalmopathy.

Authors:  I R Jones
Journal:  Postgrad Med J       Date:  1987-09       Impact factor: 2.401

4.  Intravenous methylprednisolone in the treatment of Graves' ophthalmopathy.

Authors:  P Kendall-Taylor; A L Crombie; A M Stephenson; M Hardwick; K Hall
Journal:  BMJ       Date:  1988-12-17

Review 5.  Ocular manifestations of Graves' disease: a review.

Authors:  A P Weetman; A M McGregor; R Hall
Journal:  J R Soc Med       Date:  1984-11       Impact factor: 5.344

6.  Ocular manifestations of Graves' disease.

Authors: 
Journal:  J R Soc Med       Date:  1985-05       Impact factor: 5.344

7.  The ophthalmopathy of Graves' disease.

Authors:  D Rapoport
Journal:  West J Med       Date:  1985-04

8.  Treatment of Graves' ophthalmopathy with cyclosporin A.

Authors:  A Witte; R Landgraf; A Markl; K P Boergen; G Hasenfratz; C R Pickardt
Journal:  Klin Wochenschr       Date:  1985-10-01

9.  The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota.

Authors:  G B Bartley
Journal:  Trans Am Ophthalmol Soc       Date:  1994

10.  Use of eye muscle antibody measurements to monitor response to plasmapheresis in patients with thyroid-associated ophthalmopathy.

Authors:  C Atabay; M Schrooyen; Z G Zhang; M Salvi; D Glinoer; J R Wall
Journal:  J Endocrinol Invest       Date:  1993-10       Impact factor: 4.256

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.